Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT02888938
Other study ID # 2014/PasserelleEchoSPA-Loeuill
Secondary ID
Status Recruiting
Phase N/A
First received August 31, 2016
Last updated August 31, 2016
Start date January 2015
Est. completion date July 2017

Study information

Verified date August 2016
Source Central Hospital, Nancy, France
Contact Damien Loeuille, Pr
Email d.loeuille@chru-nancy.fr
Is FDA regulated No
Health authority France: Ethics Committee
Study type Observational

Clinical Trial Summary

The aims of this study are: 1° to assess the value of pelvic radiography and sacro-iliac joint (SIJ) MRI compared to CT scan of SIJ for the diagnosis of structural sacro-iliitis and 2° to quantify structural elementary lesions on MRI and for the first time on CT-scan according to a SPARCC approach in a cohort of patients with a suspicion of spondyloarthritis (ECHOSpA).


Description:

Among the 489 patients of the cohort, MRI and CT examination of SIJ were performed simultaneously with pelvic radiographs in 173 patients. After harmonization, readers will be tested for inter-reader reproducibility for modified New York criteria, and scoring of each structural elementary lesion depicted on MRI (erosions, fat metaplasia, backfill, sclerosis and ankylosis) and on CT-scan (erosion, joint space narrowing, sclerosis and ankylosis). When acceptable inter-reader reproducibility will be obtained, exams will be blindly and independently scored by 2 readers (rheumatologist and/or radiologist) in the following order: 1/ pelvic radiographs, 2/ MRI, 3/ CT-scan. In case of discordance between readers for the diagnosis of sacroiliitis, an adjudicator will define the final diagnosis for each imaging method (senior rheumatologist or radiologist). Severity of each structural lesion will be scored quantitatively according to structural SPARCC approach. Only lesions observed in the synovial part of the SIJ on 2 successive slices will be taken into account.

Sensibility, specificity and concordance for the diagnosis of structural sacroiliitis for radiograph and MRI will be calculated with the CT-scan considered as the gold standard. Quantitative MRI and CT scores will be compared for each lesion: erosion, sclerosis and ankylosis. This quantitative approach will be used to explain cases of discordance or concordance for radiograph and MRI.


Recruitment information / eligibility

Status Recruiting
Enrollment 173
Est. completion date July 2017
Est. primary completion date July 2017
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Patients with suspected spondyloarthritis

Exclusion Criteria:

Study Design

Observational Model: Cohort, Time Perspective: Cross-Sectional


Related Conditions & MeSH terms


Intervention

Other:
pelvic radiography

pelvic MRI

pelvic CT-scan


Locations

Country Name City State
France Service deRhumatologie - CHRU Brabois Vandoeuvre les Nancy

Sponsors (2)

Lead Sponsor Collaborator
Central Hospital, Nancy, France Pfizer

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Diagnostic value of pelvic radiograph compared to CT-scan of sacro-iliac joint for the diagnosis of structural sacroiliitis according to New York criteria; CT-scan considered as the gold standard baseline No
Primary Diagnostic value of MRI of sacro-iliac joint compared to CT-scan of sacro-iliac joint for the diagnosis of structural sacroiliitis according to New York criteria; CT-scan considered as the gold standard baseline No
Primary Quantitative assessment of structural lesions of sacro-iliac joints on CT-scan according to SPARCC for structural assessment and adapted for CT-scan baseline No
Primary Quantitative assessment of structural lesions of sacro-iliac joints on MRI according to SPARCC baseline No